Apomorphine does not influence olfactory thresholds in Parkinson's disease

Functional Neurology

Volumn 13, Issue 2, 1998, Pages 99-103

  Roth, Jan ^a,c   Radil, Tomáš ^b   Růžička, Evžen ^a   Jech, Robert ^a   Tichý, Jiří ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c Clinic of Neurology   (Czech Republic)

Author keywords

Apomorphine; Olfaction; Parkinson's disease

Indexed keywords

APOMORPHINE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; FEMALE; HUMAN; MALE; MOTOR ACTIVITY; OLFACTORY EPITHELIUM; PARKINSON DISEASE; PHARMACODYNAMICS; PRESYNAPTIC INHIBITION; SMELLING; STIMULUS RESPONSE;

AGED; APOMORPHINE; DOPAMINE AGONISTS; HUMANS; MIDDLE AGED; MOVEMENT; OLFACTORY PATHWAYS; PARKINSON DISEASE; SENSORY THRESHOLDS;

EID: 0031809175     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. Journal of Chronic Diseases 1975;28:493-497
2. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988; 38:1237-1244
3. Doty RL, Riklan M, Deems DA, Reynolds C, Stellar S. The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol 1989;25:166-171
4. Doty RL. Olfactory dysfunction in neuro-degenerative disorders. In: Getchell TV ed Smell and Taste in Health and Disease. New York; Raven Press 1991:735-751
5. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:138-142
6. Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 1993;43:962-965
7. Hughes AJ, Lees AJ, Stern GM. Apomorphine test to predict dopaminergic responsivenesss in parkinsonian syndromes. Lancet 1990; ii:32-34
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442
9. Ward CD, Gibb W. Research diagnostic criteria for Parkinson's disease. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH eds Advances in Neurology, Vol. 53, Parkinson's Disease: Anatomy, Pathology and Therapy. New York; Raven Press 1990:943-946
10. Duvoisin RC. The evaluation of extrapyramidal disease. In: Ajuriagerra J ed Monoamines, noyaux gris centraux et syndrome de Parkinson. Symposium Genève. Paris; Masson 1970:313-325
11. Radil T, Roth J, Růžička E, Tichý J, Wysocki CJ. Olfactory dysfunction in Parkinson's disease. Zdravniški Vestnik 1996;65 (Suppl 3):63-64
12. Nieuwenhuys R. Survey of chemically defined cell groups and pathways. In: Nieuwenhuys R ed Chemoarchitecture of the brain. Berlin, Heidelberg; Springer Verlag 1985:14-19
13. Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden CD, Fahn S eds Movement Disorders. New York, London; Butterworth's 1987:166-231
14. Javoy-Agid F, Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology 1980;30:1326-1330
15. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995;10:283-287
16. Quinn NP, Rossor MN, Marsden CD. Olfactory thresholds in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987;50:88-89
17. Korten JJ, Meulstee J. Olfactory disturbances in parkinsonism. Clin Neurol Neurosurg 1986;112:195-197
18. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson's disease. Neurology 1983;33:943-946